logo

For the Inventor, By the Inventor

Lynnfield, MA, United States of America

Robert J Leonard

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent, primarily in Biomedical Innovations. Top assignees: Endocon, Inc., Surgic-Acid, Inc., University of Florida Research Foundation Inc.. Active years: 1988-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert J Leonard. Retrieved from https://idiyas.com/inventor/robert-j-leonard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 100.0


Average Co-Inventor Count = 1.4

ph-index = 9

Forward Citations = 629(Granted Patents)


Location History:

  • Buena Park, CA (US) (1990)
  • Lynnfield, MA (US) (1988 - 1997)
  • Swampscott, MA (US) (2001)
  • Wellesley, MA (US) (2001 - 2002)

Company Filing History:

goldMedal7 out of 10 
 
Endocon, Inc.
 patents
silverMedal1 out of 1 
 
Surgic-Acid, Inc.
 patent
bronzeMedal1 out of 3,064 
 
University of Florida Research Foundation Inc.
 patents
4. 5 out of 834,659 
Other
 patents

Years Active: 1988-2002

Loading Chart...
Loading Chart...
Areas of Expertise:
Ischemic Damage
Testosterone Compounds
Neuronal Protection
Medicinal Implants
Biological Fluid Reduction
Drug Delivery
Peptide Pellets
Syringe Technology
Adjustable Shower Head
Dispensing Paste
Injection Systems
14 patents (USPTO):Explore Patents
1. 6339078 - Methods of prevention and treatment of ischemic damage (2002-01-15),
2. 6326365 - Methods of prevention and treatment of ischemic damage (2001-12-04),
3. 6172088 - Testosterone compounds and use for the protection of neurons (2001-01-09),
4. 5688519 - Flash-flow fused medicinal implants (1997-11-18),
5. 5449679 - Process and products for reducing biological fluid levels of a lipid (1995-09-12),
6. 5431630 - Needle guard and nonreusable syringe (1995-07-11),
7. 5409710 - Foam cell drug delivery (1995-04-25),
8. 5137669 - Manufacture of partially fused peptide pellet (1992-08-11),
9. 5039660 - Partially fused peptide pellet (1991-08-13),
10. 4994028 - Injector for inplanting multiple pellet medicaments (1991-02-19),
11. 4944049 - Adjustable shower head and clock apparatus (1990-07-31),
12. 4892734 - Dispensing paste for forming medicinal pellets (1990-01-09),
13. 4846793 - Injector for implanting multiple pellet medicaments (1989-07-11),
14. 4748024 - Flash flow fused medicinal implants (1988-05-31),

Title: Innovations by Robert J Leonard

Introduction

Robert J Leonard is a notable inventor based in Lynnfield, MA (US). He holds a total of 14 patents, showcasing his significant contributions to the field of medical science, particularly in the prevention and treatment of ischemic damage.

Latest Patents

Leonard's latest patents focus on methods of conferring protection on a population of cells associated with ischemia following an ischemic event. The invention involves providing an estrogen compound and administering an effective amount of the compound within a time frame that is effectively proximate to the ischemic event. This innovative approach aims to protect cells during critical situations such as cerebrovascular disease, stroke, myocardial infarction, and trauma. Additionally, novel methods for the intravenous administration of the estrogen compound are also included in his patents.

Career Highlights

Throughout his career, Robert J Leonard has worked with various companies, including Endocon, Inc. His work has significantly impacted the medical field, particularly in developing treatments for ischemic conditions.

Collaborations

Leonard has collaborated with notable individuals in his field, including S Mitchell Harman and James W Simpkins. Their combined expertise has contributed to the advancement of his innovative methods.

Conclusion

Robert J Leonard's contributions to the field of medical science through his patents and collaborations highlight his dedication to improving treatment methods for ischemic damage. His work continues to influence the medical community and offers hope for better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…